|
| Pronunciation |
 (hye
droks ee PROE pil meth il SEL yoo
lose) |
 |
| U.S. Brand Names |
| Gonak™[OTC]; Goniosol®[OTC] |
|
| Generic Available |
|
No |
|
| Synonyms |
| Gonioscopic Ophthalmic Solution |
|
| Pharmacological Index |
|
Ophthalmic Agent, Miscellaneous |
|
| Use |
|
Ophthalmic surgical aid in cataract extraction and intraocular implantation; gonioscopic examinations |
|
| Pregnancy Risk Factor |
|
C |
|
| Adverse Reactions |
|
1% to 10%: Local irritation |
|
| Usual Dosage |
|
Introduced into anterior chamber of eye with 20-gauge or larger cannula |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a physician |
|
| Dosage Forms |
|
Solution: 2.5% (15 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
